Ackermann Michael

CIK 00017912492 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001791249

Recent Transactions

32 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-06-16+12,000→ 12,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-06-16+7,000→ 7,000 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-06-15−4,257→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-06-15+4,257→ 1,208,273 total
Purchase
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-05-05$13.50/sh+100,000→ 100,000 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-12-01$24.68/sh−2,054→ 1,205,353 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-12-01$25.87/sh−809→ 1,204,544 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-12-01$23.85/sh−2,442→ 1,207,407 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-12-01$26.65/sh−528→ 1,204,016 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-01$27.76/sh−4,964→ 1,210,718 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-01$28.18/sh−869→ 1,209,849 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-10-12$26.45/sh−4,517→ 1,215,682 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-10-12$25.56/sh−1,116→ 1,220,199 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-10-08$25.03/sh−200→ 1,221,315 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-09-01$25.24/sh−5,833→ 1,221,515 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-11$25.15/sh−621→ 1,227,348 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-09$25.00/sh−700→ 1,227,969 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-06$25.00/sh−3,129→ 1,228,669 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-05$25.00/sh−100→ 1,231,898 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-05$25.00/sh−1,183→ 1,231,998 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-08-05$25.01/sh−100→ 1,231,798 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2021-06-15+4,257→ 4,257 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-06-15+4,257→ 1,233,181 total
Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Series B Preferred Stock
2020-10-20−9,246→ 0 total
Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2020-10-20+9,246→ 1,228,924 total
Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Series A Preferred Stock
2020-10-20−53,939→ 0 total
Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2020-10-20+53,939→ 1,219,678 total
Award
Oyster Point Pharma, Inc.
Common Stock
2020-06-08+14,805→ 152,162 total
Conversion
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04+140,567→ 140,567 total
Conversion
Oyster Point Pharma, Inc.
Series A Convertible Preferred Stock
2019-11-04−140,567→ 0 total

Companies

Recent Filings

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540

View on SEC.gov